
CREM 抑制因子 | SCBIO - Santa Cruz Biotechnology
crem 抑制剂是一类化学化合物,旨在选择性地、逆转录地靶向被称为 camp 应答元件调节剂 (crem) 的转录因子。 CREM 是基因表达的重要调节因子,对细胞中的 cAMP 信号通路做出反应。
Targeting phosphodiesterase 4 as a potential therapeutic strategy …
Inhibition of PDE4 by rolipram and HT-0712 activates cAMP/CREB signaling, enhances cognitive function, and restores motor skill after cerebral ischemia 102. Notably, PDE4 inhibitors facilitate behavioral recovery and cortical reorganization to a significantly greater level when comparing to the rehabilitation alone 102.
DC591017, a phosphodiesterase-4 (PDE4) inhibitor with robust …
2020年7月1日 · Phosphodiesterase-4 (PDE4) functions as a critical intracellular enzyme in immune cells and keratinocytes through the hydrolysis of cAMP. Inhibition of PDE4 has been considered as an effective therapeutic strategy in multiple inflammatory diseases.
Identification of phosphodiesterase-4 as the ... - ScienceDirect
2021年11月1日 · PDE4 inhibition by arctigenin resulted in elevation of intracellular cyclic adenosine monophosphate (cAMP) and phosphorylation of cAMP-response element binding protein (CREB), which were largely blocked through intervention of protein kinase A (PKA) activity by H89 treatment or reduction of protein expression by siRNA transfection.
Rolipram, a Phosphodiesterase 4 Inhibitor, Stimulates Inducible …
This study investigated the effect of a PDE4 inhibitor on the expression of the inducible cAMP early repressor (ICER), which is an endogenous inhibitor of CRE-mediated transcription, in osteoblastic cells. RT-PCR analysis revealed that rolipram, a PDE4 inhibitor, stimulates the ICER mRNA in a dose dependent manner.
Frontiers | A mini-review: phosphodiesterases in charge to balance ...
2024年3月7日 · So far, PDE4 is the best-described PDE in T-cells and the first PDE that is currently targeted in clinical practice to treat autoimmune diseases. But also, other PDE families harbor additional therapeutic potential. PDE2A is a dual-substrate phosphodiesterase which is selectively upregulated in Tcon upon activation.
Phosphodiesterase 4 inhibition after retrieval switches the ... - Nature
2023年11月21日 · Phosphodiesterase 4 (PDE4), an enzyme expressed in the dorsal hippocampus (DH), hydrolyzes the cAMP, limiting the PKA-induced CREB phosphorylation (pCREB) and BDNF...
CREM Gene - GeneCards | CREM Protein | CREM Antibody
2024年12月24日 · CREM (CAMP Responsive Element Modulator) is a Protein Coding gene. Diseases associated with CREM include Female Stress Incontinence and Infertility. Among its related pathways are Activation of cAMP-Dependent …
磷酸二酯酶4抑制剂在风湿免疫性疾病治疗中的应用
2023年12月16日 · pde4抑制剂通过抑制pde4对camp的水解,从而提高胞内camp的浓度。 高水平的cAMP能激活磷酸激酶A(protein kinase A,PKA)和cAMP激活的交换蛋白1/2(exchange protein activated by cAMP1/2,Epac1/2),从而调节多种信号通路[11]。
Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory ...
PDE4 inhibitors developed for the treatment of IBD. Patients suffering from Crohn's diseases (CD) and UC mostly manifest with severe diarrhea, fecal urgency, body weight loss, hematochezia, incontinence, and abnormal pain and even with fever caused by plethoric inflammation in the gut that lasts for weeks to months (Kumar et al., 2013). The ...
- 某些结果已被删除